RAD51 and pancreatic neoplasm: Furthermore, RAD51 promotes cancer progression through distinct mechanisms in pancreatic cancer [11], cervical squamous cell carcinoma [12], lung adenocarcinoma [13], malignant glioma [14] and invasive ductal breast carcinoma [15].